By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panelists agreed that the commercial viability of quantum hardware/software is unproven at scale, with IBM offering a more stable investment due to its diversified revenue and services, while Xanadu (XNDU) is more speculative, relying on photonic qubits and a thin revenue base.
Risk: the commercial viability of quantum hardware/software is unproven at scale
Opportunity: a big enterprise cloud deal for photonic QC could compress XNDU's risk premium far faster than IBM's gradual services ramp
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Xanadu Quantum Technologies Limited (NASDAQ:XNDU) was among the stocks Jim Cramer discussed during Mad Money, as he highlighted a difficult backdrop for stocks. When a caller expressed bullishness on the stock, Cramer replied:
No, no, no, that makes no money. It’s another one of these quantum ones that I don’t… Buy IBM if you want quantum, okay? Buy IBM. But I appreciate the sentiment.
Photo by Adam Nowakowski on Unsplash
Xanadu Quantum Technologies Limited (NASDAQ:XNDU) develops photonic quantum computing hardware and software, providing cloud-based access to programmable quantum computers together with tools for quantum programming, simulation, and algorithm optimization.
While we acknowledge the potential of XNDU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"The core takeaway is: don't assume IBM is the only viable path to quantum value; Xanadu's photonic approach could outperform if it secures early enterprise traction, otherwise IBM's diversified revenue base keeps it safer."
Cramer's take underscores a broader market view: quantum investing remains a multi-year/stage game, favoring scale and near-term monetization. IBM offers diversified revenue and a clearer path to monetizing quantum via services, while Xanadu (XNDU) is far more speculative—relying on photonic qubits, a cloud model, and a thin revenue base. The article glosses over the fundamental risk: the commercial viability of quantum hardware/software is unproven at scale, and a single enterprise win or software moat could swing Xanadu much more than a slow ramp of IBM quantum revenue. Missing context includes Xanadu's partnerships, burn rate, and profitability timeline.
IBM's quantum bets might stall on timing and cost, and Xanadu's photonic QC could win first-mover cloud traction; if Xanadu secures a strategic enterprise deal this year, XNDU could re-rate despite weak current revenues.
"Investing in IBM for quantum exposure is a fundamental category error that prioritizes legacy stability over the actual technological disruption occurring in the photonic quantum space."
Cramer’s dismissal of XNDU in favor of IBM ignores the massive delta between legacy enterprise tech and pure-play quantum innovation. IBM is a dividend-paying, mature conglomerate where quantum is a rounding error on the balance sheet, whereas XNDU is focused on photonic quantum computing, which addresses the decoherence and scalability issues plaguing superconducting qubits. Betting on IBM for quantum exposure is like buying an oil major to bet on fusion energy; you’re buying a value play, not a breakthrough technology play. Investors chasing quantum alpha need to understand that XNDU’s photonic approach could leapfrog IBM’s current roadmap if they achieve fault tolerance first.
The counter-argument is that quantum computing is still largely theoretical at scale, making XNDU’s cash burn rate a terminal risk compared to IBM’s massive free cash flow and established enterprise moat.
"XNDU's lack of revenue is a real problem, but Cramer's IBM alternative is equally unprofitable—this is a 'pick your poison' choice between two speculative bets, not a clear winner."
Cramer's dismissal of XNDU hinges on 'makes no money'—a legitimate profitability critique for pre-revenue quantum plays. But the article itself is promotional dreck masquerading as news, pushing unnamed 'AI stocks' while burying XNDU's actual tech (photonic quantum, not gate-based). IBM's quantum division is also unprofitable and years behind competitors like IonQ on key benchmarks. The real signal here isn't Cramer's opinion—it's that retail is chasing quantum hype without distinguishing between architectures or commercialization timelines. XNDU trades on sentiment, not fundamentals, making it a speculative bet, not an investment.
Photonic quantum (XNDU's approach) may actually scale more efficiently than superconducting qubits long-term, and IBM's recommendation could simply reflect brand-name bias rather than technical superiority. If XNDU reaches profitability before IBM's quantum division, Cramer's blanket dismissal looks foolish in hindsight.
"Xanadu offers no credible path to profitability in the next five years, making IBM the only rational quantum proxy among the two."
Cramer's blunt dismissal of XNDU underscores its pre-revenue status and the broader difficulty of monetizing quantum hardware today, favoring IBM's more mature quantum division within a profitable services business. The piece pivots quickly to unrelated AI names and tariff plays, glossing over execution risks in photonic quantum systems and the capital intensity required before any commercial scale. Investors chasing pure quantum exposure face dilution and timeline uncertainty that even bullish sentiment cannot offset near-term.
Xanadu's photonic architecture may avoid the error-correction hurdles plaguing IBM's superconducting approach, positioning it for a technical leap that renders today's revenue concerns irrelevant if milestones are hit by 2027.
"A big enterprise cloud deal for XNDU could re-rate the stock faster than IBM's services ramp, but the real risk is lack of open standards and interoperability."
Claude, you're right XNDU is pre-revenue, but you understate optionality in adoption. A big enterprise cloud deal for photonic QC could compress XNDU's risk premium far faster than IBM's gradual services ramp. The real overlooked risk is standards/interoperability: without open QC stacks, hyperscalers may resist lock-in, ceding early wins to a couple of players and leaving the rest sidelined. If XNDU builds a de facto standard, upside dwarfs today's gross burn.
"Control of the software ecosystem, specifically developer-friendly stacks like PennyLane, is more critical to long-term valuation than hardware architecture or current revenue."
ChatGPT, your focus on 'standards' ignores the hardware-software decoupling trend. In quantum, the software layer—Qiskit for IBM or PennyLane for Xanadu—is the real moat. If Xanadu’s PennyLane becomes the industry-standard software stack, they win the developer ecosystem regardless of whose hardware scales first. Gemini and Grok are missing this: the battle isn't just about qubit architecture; it’s about which company controls the developer workflow and the resulting data gravity in a hybrid-cloud environment.
"Software moats in quantum are premature; hardware delivery timelines and actual qubit fidelity determine winners, not developer adoption of open frameworks."
Gemini's software-moat argument is seductive but inverts the actual risk. PennyLane is open-source; developers aren't locked in. IBM's Qiskit faces identical fragmentation. The real lock-in is *hardware availability*—if Xanadu's photonic systems can't deliver usable qubits at scale by 2026, PennyLane becomes a SDK for a ghost platform. Software gravity requires hardware gravity first. Neither company has proven that yet.
"Hardware differentiation must precede software moats in quantum, amplifying timeline risks for Xanadu beyond 2026."
Claude, the open-source nature of both PennyLane and Qiskit highlights a deeper issue: without differentiated hardware performance by 2026, neither stack captures value as competitors like IonQ or Google integrate alternatives. This connects to ChatGPT's interoperability point—fragmentation risks diluting any single player's moat, especially for capital-intensive photonic systems where Xanadu's burn could outpace adoption.
The panelists agreed that the commercial viability of quantum hardware/software is unproven at scale, with IBM offering a more stable investment due to its diversified revenue and services, while Xanadu (XNDU) is more speculative, relying on photonic qubits and a thin revenue base.
a big enterprise cloud deal for photonic QC could compress XNDU's risk premium far faster than IBM's gradual services ramp
the commercial viability of quantum hardware/software is unproven at scale